SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
Clinical trial NCT04269642 · UNKNOWN
Trial details
- NCT number
- NCT04269642
- Sponsor
- Peptron, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-19
- Primary completion
- 2021-09-29
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.